These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis. Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153 [No Abstract] [Full Text] [Related]
9. Therapy options in pulmonary alveolar proteinosis. Luisetti M; Kadija Z; Mariani F; Rodi G; Campo I; Trapnell BC Ther Adv Respir Dis; 2010 Aug; 4(4):239-48. PubMed ID: 20647242 [TBL] [Abstract][Full Text] [Related]
10. Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMT. Cooke KR; Nishinakamura R; Martin TR; Kobzik L; Brewer J; Whitsett JA; Bungard D; Murray R; Ferrara JL Bone Marrow Transplant; 1997 Oct; 20(8):657-62. PubMed ID: 9383229 [TBL] [Abstract][Full Text] [Related]
11. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis]. Xu KF; Chen Y; Guo ZJ; Zhu YJ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF. Price A; Manson D; Cutz E; Dell S Pediatr Pulmonol; 2006 Apr; 41(4):367-70. PubMed ID: 16475176 [No Abstract] [Full Text] [Related]
13. Lack of GM-CSF as a cause of pulmonary alveolar proteinosis. Hallman M; Merritt TA J Clin Invest; 1996 Feb; 97(3):589-90. PubMed ID: 8609211 [No Abstract] [Full Text] [Related]
14. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice. Seymour JF Respirology; 2006 Jan; 11 Suppl():S16-22. PubMed ID: 16423263 [TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report. Tazawa R; Nakata K; Inoue Y; Nukiwa T Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of surfactant protein production in a mouse model of secondary pulmonary alveolar proteinosis. Shibasaki M; Hashimoto K; Okamoto M; Hayashi Y; Imaizumi K; Hashimoto N; Ozaki N; Yokoi T; Takagi K; Hasegawa Y; Shimokata K; Kawabe T Am J Respir Cell Mol Biol; 2009 May; 40(5):536-42. PubMed ID: 18931325 [TBL] [Abstract][Full Text] [Related]
17. [Clinical, biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism: SP-B deficiency and alveolar proteinosis]. Tredano M; Blic JD; Griese M; Fournet JC; Elion J; Bahuau M Ann Biol Clin (Paris); 2001; 59(2):131-48. PubMed ID: 11282516 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401 [TBL] [Abstract][Full Text] [Related]
20. Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung? Nakata K; Kanazawa H; Watanabe M Respirology; 2006 Jan; 11 Suppl():S65-9. PubMed ID: 16423275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]